Childhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Because of improved tumor detection and treatment advances in recent decades, 84% of children with cancer now survive 5 years or more. However, cancer is still the first cause of death by disease among children in the U.S and 95.5% of the survivors will suffer from chronic health conditions by the age of 45. Oncoheroes Biosciences is working to reverse this situation by developing new pediatric oncology medicines.
We are excited to announce the investment of the Scott Carter Foundation (SCF), a childhood cancer non-profit located in Tulsa, Oklahoma founded in memory of Scott Carter, a 13-year old boy who died of osteosarcoma after a courageous three-year battle. During his fight against the disease, Scott built a remarkable collection of sports and celebrity memorabilia which he called “Scott Carter’s Heroes”. His dream was to display the collection for the enjoyment of the public and to raise money for children’s cancer research.
“It is appalling to note that a child diagnosed today would likely receive exactly the same treatment that was given to our son Scott as he battled bone cancer over thirty years ago. Today we have been given an opportunity of which we could only dream - the opportunity to become partners with a biotech company that is 100% focused on pediatric cancers,” statedPaula Carter, co-founder and Executive Director of the Scott Carter Foundation. “It is with great pride and pleasure that the SCF has decided to join the efforts of Oncoheroes Biosciences so that we may move forward together, into the future with more hope than ever before of finding a cure for every child”.
The Scott Carter Foundation has focused its efforts on finding a cure for every child for over 28 years. In their attempt to “research the research”, they have found that thousands of research doctors across the US, Europe, and Canada give their lives to the search for a cure. Many, if not most of the greatest research projects remain underfunded. Thus, the Scott Carter Foundation has supported research fellowships at several institutions including M.D. Anderson, Texas Children’s Hospital, Children’s Hospital of Los Angeles, Duke University Medical Center among others. This is the first time the SCF is investing in a biotech company.
“What an exciting Childhood Cancer Awareness Month! Scott Carter Foundation is the fourth foundation joining Oncoheroes within the last three weeks,” said Ricardo Garcia, co-founder, and CEO of Oncoheroes Biosciences. “Thank you, Scott Carter Foundation, for the confidence and for getting onboard with this unique endeavor”.
